These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20159827)

  • 1. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms.
    Piva R; Agnelli L; Pellegrino E; Todoerti K; Grosso V; Tamagno I; Fornari A; Martinoglio B; Medico E; Zamò A; Facchetti F; Ponzoni M; Geissinger E; Rosenwald A; Müller-Hermelink HK; De Wolf-Peeters C; Piccaluga PP; Pileri S; Neri A; Inghirami G
    J Clin Oncol; 2010 Mar; 28(9):1583-90. PubMed ID: 20159827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
    Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
    Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
    Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
    Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
    Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
    Salaverria I; Beà S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
    Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma.
    Sjostrom C; Seiler C; Crockett DK; Tripp SR; Elenitoba Johnson KS; Lim MS
    Exp Hematol; 2007 Aug; 35(8):1240-8. PubMed ID: 17560012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
    Ladanyi M
    Cancer Surv; 1997; 30():59-75. PubMed ID: 9547986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site.
    Ladanyi M; Cavalchire G
    Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study.
    Youssif C; Goldenbogen J; Hamoudi R; Carreras J; Viskaduraki M; Cui YX; Bacon CM; Burke GA; Turner SD
    Genes Chromosomes Cancer; 2009 Nov; 48(11):1018-26. PubMed ID: 19691112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas.
    Tan BT; Seo K; Warnke RA; Arber DA
    J Mol Diagn; 2008 Nov; 10(6):502-12. PubMed ID: 18832464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric detection of circulating tumour cells in nucleophosmin/anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: comparison with quantitative polymerase chain reaction.
    Damm-Welk C; Schieferstein J; Schwalm S; Reiter A; Woessmann W
    Br J Haematol; 2007 Aug; 138(4):459-66. PubMed ID: 17608768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
    Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T
    Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase".
    Lu Y; Zhao X; Wang E; Chen W; Huang Q
    Leuk Res; 2010 Apr; 34(4):475-82. PubMed ID: 19695703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
    Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
    Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
    Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P
    Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project.
    Weisenburger DD; Anderson JR; Diebold J; Gascoyne RD; MacLennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Armitage JO
    Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
    Hsu FY; Zhao Y; Anderson WF; Johnston PB
    Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.